Back
ePlus Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Buy
59
PLUS
ePlus
Last Price:
$82.19
Seasonality Move:
0.19%
Sell
10
CRNX
Crinetics Pharmaceuticals
Last Price:
$38.82
Seasonality Move:
-1.28%
Sell
10
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $37.35. The Score for CRNX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
PLUS Stock Price Chart
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $37.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.
PLUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 61.25 | Buy |
Chaikin Money Flow: | -72535 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (73.65 - 78.37) | Buy |
Bollinger Bands (100): | (78.44 - 97.2) | Sell |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.86 | Sell |
Relative Strength Index (14 RSI): | 24.86 | Sell |
Chaikin Money Flow: | -35896 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.32 - 56.24) | Sell |
Bollinger Bands (100): | (48.55 - 58.57) | Sell |
PLUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 77.73 | Buy |
20-day SMA: | 75.45 | Buy |
50-day SMA: | 80.23 | Sell |
200-day SMA: | 83.64 | Sell |
8-day EMA: | 78.14 | Buy |
20-day EMA: | 77.24 | Buy |
50-day EMA: | 80.28 | Sell |
200-day EMA: | 82.21 | Sell |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.46 | Sell |
20-day SMA: | 47.63 | Sell |
50-day SMA: | 53.38 | Sell |
200-day SMA: | 50.82 | Sell |
8-day EMA: | 40.25 | Sell |
20-day EMA: | 45.8 | Sell |
50-day EMA: | 50.67 | Sell |
200-day EMA: | 49.24 | Sell |
ePlus Earnings Growth & PLUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.53 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
ePlus Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |